Neuroendocrine Tumor G2 — Trials

Neuroendocrine Tumor G2 — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03879694	Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors	completed	Phase 1	19	Roswell Park Cancer InstituteOTHER	1	Feb 6, 2026	clinicaltrials
NCT06080204	Real-world Study on Adjuvant Octreotide Therapy in pNETs	completed	N/A	411	Changhai HospitalOTHER	0	Oct 18, 2023	clinicaltrials
NCT02893930	Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery	completed	Phase 2	13	National Cancer Institute (NCI)NIH	1	Oct 17, 2023	clinicaltrials
NCT01229943	Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery

Data updated 22 days agoSource updated Feb 6, 2026source: clinicaltrials